ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome
Year: 2012
Type: article
Study design: Observational Study
Source: Leukemia
DOI: 10.1038/leu.2012.262
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2073358532
